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Pyuria is usually present in patients with urinary tract infections. Therefore, it
is surprising that the host defense function of polymorphonuclear leukocytes
(PMNs) in urine is not well understood. Studies by Chernew and Braude demon-
strated that urine suppressed PMN phagocytic function in an environment contain-
ing 7-8% serum (1). Similarly, studies by Norden, Green, and Kass suggested
that PMNs did not contribute significantly to eradication of bacteria in the experi-
mentally-infected rat bladder (2). Conversely, observations by Kaye and Cobb in-
dicated that PMNs might play an active role in defense against bladder infection
(3).
In the present studies, leukocyte migration, adhesion to glass, aggregation by
endotoxin, and phagocytosis of bacteria were tested in urine in order to evaluate
the host defense function of PMNs in urine. In addition, experiments were per-
formed to differentiate changes in leukocyte behavior attributable to cell injury in
urine from changes caused by the absence of plasma proteins. In the latter experi-
ments, leukocyte function was tested in plasma after incubation of leukocytes in
urine. The time required for cell injury in urine was assessed. Factors in urine which
were tested individually for their toxicity to leukocytes included hyperosmolality,
increased hydrogen ion concentration, and increased urea concentration. In addi-
tion, studies were performed to determine the effect of opsonins on leukocyte
phagocytic function in urine.
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METHODS AND MATERIALS
Blood from normal human donors was heparinized to a final concentration of
3.3 mg/100 ml. Leukocyte-rich plasma (LRP) was prepared as follows. Tubes
containing 15 ml of heparinized whole blood were centrifuged for 10 min at 500g.
Two-thirds of the red cell layer was removed, remaining cells and plasma were
mixed and sedimented at 370C for about 1 hr. The leukocyte-rich plasma super-
natant (LRP) obtained by this method contained approximately 60% polymor-
phonuclear (PMN) leukocytes by differential count.
Serum was prepared by centrifugation of blood collected in plain vacutainer
tubes and allowed to clot. In certain studies, serum was heparinized (3.3 mg
heparin/100 ml serum). Fresh, autologous plasma or serum was used in experi-
ments testing leukocyte function.
Urine was supplied by one normal male donor. Specific gravity of specimens
was measured at 250C with a urinometer, and osmolality (mosm/kg H20) with
an osmometer. Specimens were selected for experimentation on the basis of desired
specific gravity and osmolality. Urine was sterilized by filtering through a
0.45 ,tm Millipore field monitor and stored in sterile glass containers at 40C. Prior
to use, specimens were warmed to 370C in a water bath. If sediment formed at
40C did not dissolve, urine was refiltered. In certain studies, the pH of urine speci-
mens was varied by addition of HCl or NaOH. After experiments had been con-
cluded, specimens were centrifuged and supernatant fluids examined to determine
osmolality, pH, and ionic strength of urine or other solutions incubated with
leukocytes.
Buffered electrolyte solution (BES) used in these studies contained 125 mM
NaCI, 2.7 mM KCl, 1.8 mM CaC12, 11 mM glucose, and 23.8 mM Trizma Base
dissolved in distilled water and adjusted to a pH of 7.5 with 6 N HCl. This solution
was sterilized by filtration through a 0.45 Mm Millipore field monitor.
Leukocyte functions tested in these studies were migration in 32-mm glass capil-
lary tubes, adhesion to 32-mm glass capillary tubes, aggregation after exposure
to E. coli endotoxin, and phagocytosis of Staphylococcus aureus. All experiments
were performed using a double blind technique.
I. Leukocyte Function in Normal Urine
Migration. Tubes containing 2 ml of LRP were centrifuged at 250g for 3 min.
Each cell pellet was suspended in 2 ml of urine (osmolality shown in Table 1).
Two ml of fresh plasma were added to cells in the control tube. These test mixtures
were used to fill 32-mm glass capillary tubes (10 tubes per variable). One end
of each capillary tube was flame-sealed. Tubes were centrifuged for 2 min in a
Drummond microhematocrit centrifuge and then taped to a large glass microscope
slide. The slide was placed on a vertically positioned microscope stage in a 370C
incubator. Measurement of vertical progression of leukocytes from the buffy coat
was made with an ocular micrometer after 4 hr of incubation (4). Migration in
urine was expressed as percent of control migration in fresh plasma.
Adhesion. Test mixtures prepared like those used for migration studies were
loaded into 32-mm glass capillary tubes (10 tubes per variable), and one end was
flame-sealed. Tubes were incubated in a horizontal position for 30 min at 370C,
then centrifuged for 1 min in a Drummond microhematocrit centrifuge. Tubes were
next mounted with the cell-adherent surface facing upward on a large glass micro-
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TABLE 1
LE:-KOCYTE FUTNCTION IN NOTIMAL ITRINE.'
Osinolality 'Migration Adhesion index Aggregatioii (% Phlagocytosis
(mosin/kg I0) (% of control)> (%7 of control)b PMINs in aggregates)c (% of control)d
100-2()( 0 1 + 0.4 0.5
300-400 0 0.7 ± 0.3 2.8 ± 0.9 0
400-600 0 0 0
600-800 0 4 ± 1.3 0
800-1100 0 1 ± 0.3 0.3 + 0.3 0
280 (plasia or
seruimi control) 10Oe 100of 83.9 + 1.5 100(
M lean s of 3 experl'ienIts.
b MteaIns of 2 experimlents + SEAM.
cMNleans of 2 experimnents; aggregationi of PMNINs iinduce(lhy E. coli eIndotoxini; imean value for
controls witlhout enedotoxin were 4.3 ± 1.5, 0, 0.3 ± 0.3, 1.1 + 0.5, respectively.
d MNleans of 2 experinieiits.
e CoIntr-ol Imigrationi = 1.25 mImIl.
f 'Mean conitrol a(llIesioli inidex = 538 cells/m111m2.
a Conitrol plhagocytic iIl(lex = 1119 bacteria/100 PMNs.
scope slide. The slide was placed on a vertically positioned microscope stage in a
370C incubator. Enumeration of cells adhering to a 0.1 X 5.0 mm area in the
midportion of the tubes was performed with an ocular micrometer (5). Adhesion
in urine was expressed as percent of control adhesion in fresh plasma.
Aggregation. LR;P was centrifuged in 10-ml aliquots at 130g for 10 min, and
the sedimented cells were suspended in fresh plasma to a final concentration of
approximately 10, leukocytes/ml. Test mixtures were prepared as follows. Tubes
containing 1.8 ml of LRP were centrifuged at 130g for 5 min. Plasma was re-
moved, and each cell pellet was suspended in 1.8 ml of urine (osmolality as indi-
cated in Table 1). Tubes were centrifuged again, urine removed, and cells were
suspended in 1.8 ml of urine. The cell pellet for the control specimen was first
suspended in 1.8 ml of urine (450 mosm/kg, pH 7.5) and then in 1.8 ml of
heparinized serum. All test mixtures were prepared in duplicate and rotated for
30 min at 370C. One specimen of each pair received 200 ,Ag of E. coli endotoxin
in saline, and the other received an equal volume of isotonic saline (controls).
After rotation on a rotary wheel for 20 min at 370C, a small sample of test mixture
from each tube was transferred to a clean sterile tube. An equal volume of
heparinized serum was mixed with each sample. Cover slip smears were made im-
mediately after the addition of serum to each sample. Smears were stained with
Wright's stain. The percent of 500 PMNs present in aggregates was determined
microscopically. An aggregate was defined as three or more adjoining leukocytes.
Phagocytosis. The organism used was Staphylococcus aureus, strain 209P. Cul-
tures grown in trypticase soy broth for 18 hr usually yielded 109 bacteria/ml. Test
mixtures were prepared as follows. Tubes containing 2.5 ml of LRP were centri-
fuged at 130g for 5 min. Each cell pellet was suspended in 2.5 ml of BES. Speci-
mens were centrifuged again, and each cell pellet was suspended in 2.5 ml of urine
(osmolality as shown in Table 1) or plasma (control). The last two steps were
repeated once before addition of bacteria to each specimen in an approximate ratio
of 10 bacteria/PMN. After rotation for 20 min at 370C tubes were centrifuged
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at 130g for 5 min, and each cell pellet was suspended in 1.8 ml of BES. Four
hundred eighty units of lysostaphin, an enzyme which lyses extracellular staphylo-
cocci but which does not affect intracellular staphylococci, were mixed with the
contents of each tube (6). Test mixtures were incubated for 35 min at 370C, cen-
trifuged at 130g for 5 min, and each cell pellet was suspended in fresh plasma.
Cover slip smears were made and stained with Wright's stain. Phagocytosis was
quantitated microscopically at 1250 X by determining the number of bacteria in
100 PMNs. This number was designated as the phagocytic index. Phagocytic in-
dices were expressed as percent of control.
11. Leukocyte Function in Plasma After Incubation in Urine
Migration and adhesion. Duplicate test mixtures were prepared for each migra-
tion and adhesion experiment using methods described above. One set of urine-
leukocyte mixtures was rotated for 15 min at 370C and the other set for 60 mi
at 370C. After rotation, tubes were centrifuged for 3 min at 250g, and each cell
pellet was suspended in 2 ml of fresh plasma. Capillary tubes were filled for quan-
titation of migration and adhesion using methods described above. Results were
expressed as percent of control.
Phagocytosis. Tubes containing 1.9 ml of LRP were centrifuged at 130g for
5 min, and each cell pellet was suspended in 2 ml of BES. Tubes were centrifuged
again, and each cell pellet was suspended in 2 ml of the appropriate incubating
solution indicated in Fig. 3 (i.e. urine, BES, or plasma). Centrifugation and sus-
pension were repeated. Test mixtures were prepared in duplicate. One set was in-
cubated for 15 min at 370C and the second set for 60 min at 370C. After the
incubation period, tubes were centrifuged at 130g for 5 min, and each cell pellet
was suspended in fresh plasma. Bacteria were added in a radio of approximately
five bacteria per PMN. Specimens were rotated for 30 min at 370C prior to addi-
tion of lysostaphin in a final concentration of 240 U/ml. Following an incubation
period of 35 min at 370C, smears were made and phagocytic indices determined.
Phagocytosis was expressed as percent of control.
III. Factors Affecting Cell Injury in Urine
Urine osmolality. Tubes containing 2.5 ml of LRP were centrifuged at 130g
for 5 min. Each cell pellet was suspended in 2.5 ml of urine, of BES, or of plasma
(osmolality and pH as indicated in Table 2). Specimens were rotated for 1 hr
at 370C, centrifuged at 250g for 2 min, and each cell pellet was then suspended
in 2.5 ml of fresh plasma. Capillary tubes were filled with test mixtures and migra-
tion determined. Results were expressed as percent of control.
Urine pH. Tubes containing 4 ml of LRP were centrifuged at 130g for 5 min.
Each cell pellet was suspended in 20 ml of BES at pH 5.5. After centrifugation
at 250g for 10 min, each cell pellet was suspended in 2.5 ml of either urine or
BES (pH 5.5 or pH 7.5). Cells in the control specimen were suspended in 2.5
ml of fresh plasma. Test mixtures were incubated for 1 hr at 370C, centrifuged
at 130g for 5 min, and each cell pellet was suspended in 2.5 ml of fresh plasma.
Migration was determined and expressed as percent of control.
Concentrations of urea or NaCl in BES. Tubes containing 2 ml of LRP were
centrifuged at 130g for 5 min, each cell pellet was suspended in 2 ml of BES,
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TABLE 2
EFFECT OF URINE OSMOLALITY ON INJURY OF LEUKOCYTES DURING INCUBATION IN URINE
Incubating solution Migration in plasma
Osmolality after incubation in
Type of solution pH (mosm/kg H20) urine (% of control)b
IJrine 7.4 66 0
Urine 7.5 363 106 ± 1.9
Urine 7.4 513 59 ± 4.3
Urine 7.2 722 1 ± 0.5
Urine 7.0 1029 0
BESa 7.4 286 99.8 ± 3.2
Plasma (control) 8.0 271 IOOC
a Buffered electrolyte solution.
b Means of 3 experiments ± SEM.
c Mean control migration = 1.7 mm.
and tubes were centrifuged again. The last two steps were repeated once. Each
cell pellet was then suspended in 2 ml of BES containing 170, or 340, or 690 mM
urea, or 210, or 295, or 465 mM NaCl (final concentrations). In control speci-
mens, leukocytes were suspended in 2 ml of BES without additive, or in 2 ml
of fresh plasma. The sample tubes were rotated at 370C for 15 min and centrifuged
at 130g for 5 min. Each cell pellet was then suspended in 2 ml of fresh plasma
and migration determined. Results were expressed as percent of control (migration
of cells incubated in BES without additive).
IV. Phagocytosis of Opsonized and Nonopsonized Bacteria in Urine
Bacteria were opsonized by rotating 2 ml of an 18-hr culture of S. aureus (strain
209P) with 4 ml of normal human serum for 30 min at 370C. After centrifugation
at 3000g for 20 min at 40C, bacteria were suspended in 10 ml of fresh trypticase
soy broth and centrifuged again. This step was repeated twice. Sedimented bacteria
were then suspended in 2 ml of fresh trypticase soy broth. Nonopsonized bacteria
were rotated in trypticase soy broth instead of serum but were otherwise treated
the same as opsonized bacteria. Cultures were sonicated for 10 sec before use.
Specimens from both opsonized and nonopsonized procedures contained about 109
bacteria/ml when diluted and quantitated by trypticase soy agar pour plates. Leu-
kocyte mixtures were prepared as follows. Ten milliliters of BES were mixed with
each 2-ml sample of LRP. Specimens were centrifuged at 500g for 10 min, each
cell pellet was suspended in 20 ml of BES, and specimens were centrifuged again.
Each cell pellet was then suspended in 1.8 ml of urine (477 mosm/kg) or plasma.
Duplicate specimens were prepared for each urine or plasma mixture. After incuba-
tion for 30 min at 250C, a leukocyte-urine and a leukocyte-plasma mixture were
inoculated with 0.2 ml of a 10-1 dilution of either opsonized or nonopsonized bac-
teria. (Bacteria/PMN ratios were approximately 5:1). These mixtures were ro-
tated for 20 min at 370C, transferred by sterile pipet to larger tubes, and then
mixed with 18 ml of fresh BES. Tubes were centrifuged at 5OOg for 10 min. Each
cell pellet was suspended in 1.8 ml of BES to which 480 U of lysostaphin were
added. Following incubation for 35 min at 370C, specimens were centrifuged at
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130g for 5 min. Each cell pellet was suspended in 1.8 ml of fresh plasma, and
smears were made. Phagocytic indices were determined as previously noted.
REAGENTS AND EQUIPMENT
Preservative-free heparin (Connaught, Toronto, Canada) and 0127:B8 E. coli
endotoxin (Difco Laboratories, Detroit, MI) were prepared in sterile isotonic
saline. Heparin was sterilized by filtration through a 0.45 uMm Millipore field moni-
tor (Millipore Corp., Bedford, MA). Lysostaphin (Schwarz-Mann, Orangeburg,
NY) was dissolved in a mixture of 0.145 M NaCl and 0.05 M Trizma Base (Sigma
Chemical Co., St Louis, MO) adjusted to a pH of 7.5, sterilized by Millipore
filtration, and stored at -200C. Becton-Dickinson and Co., supplied try,pticase soy
broth and agar, vacutainer tubes, and sterile, disposable Falcon test tubes used
in most experiments. Staphylococcus aureus strain 209P was obtained from Meade
Johnson, Evansville, IN. White blood cell counts were made on a Model F Coulter
Counter (Coulter Electronics, Hialeah, FL). Osmolalities were measured on an
Advanced Instruments Osmometer (Advanced Instruments, Newton Highlands,
Newton, MA). Sonication of bacterial cultures was done with a sonic oscillator
(MSE, Crawley, Sussex, England). Glassware was sterilized by heating to 1900C
for 2 hr in a dry oven. All glassware used for leukocyte studies except capillary
tubes vas siliconized (Siliclad, Clay-Adams).
RESULTS
1. Leukocyte Function in Normal Urine
As shown in Table 1, leukocyte migration and adhesion to glass were virtually
abolished in urine. Aggregation of cells observed after rotation of E. coli endotoxin
with PMNs in plasma was not observed after rotation of endotoxin with PMNs
in urine. Similarly, phagocytosis of S. aureus by PMNs was suppressed in urine.
Thus, all leukocyte functions tested were significantly inhibited by urine.
II. Leukocyte Function After Incubation in Urine
Cell injury caused by incubation of leukocytes in urine was reflected by impair-
ment of subsequent leukocyte function in plasma. Injury appeared to be correlated
with urine osmolality and length of the incubation period. Changes in leukocyte
migration are shown in Fig. 1. Migratory capacity in plasma was reduced markedly
after incubation of leukocytes in urine of high or low osmolality. Urine specimens
with osmolalities of 500-600 mosm/kg were least toxic to leukocytes. In fact, incu-
bation for 15 min in such urine actually stimulated subsequent leukocyte migratory
capacity in plasma. Figure 2 illustrates the changes in leukocyte adhesive capacity
after incubation in urine. Adhesion was abolished by urine with osmolalities greater
than 950 mosm/kg. Reduction of urine osmolality to 350-800 mosm/kg or reduc-
tion of the incubation period to 15 min produced less injury. Figure 3 shows the
effect of incubation in urine on PMN phagocytic capacity. Phagocytosis of S.
aureus by PMNs in plasma was virtually abolished by prior incubation in urine
of 570 mosm/kg for 1 hr. However, incubation for 15 min in urine with osmolali-
ties of 300-400 mosm/kg stimulated subsequent phagocytosis. Although not
shown, incubation of leukocytes in BES for either 15 or 60 min did not significantly
alter phagocytic capacity of PMNs.
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FIG. 1. Migration of leukocytes in plasma after incubation in urine for (0) 15 min
and (0) 60 min. Cell injury reflected by impaired migratory capacity was increased by
incubation in urine of high or low osmolalities and by longer periods of incubation. Results
are means of three experiments. Mean control migration at 15 min = 1.07 mm; mean control
migration at 60 min= 1.26 mm. Brackets represent standard error of the mean.
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FIG. 2. Adhesion of leukocytes to glass after incubation in urine for (0) 15 min and
(0) 60 min. Extremes of urine osmolality and longer period of exposure were associated
with impairment of this cell function. Results of 15-min incubation are means of three
experiments; mean control adhesion index = 612 cells/mm2. Results of 60-min incubation
are means of five experiments; mean control adhesion index = 582 cells/mm2. Brackets
represent standard error of the mean.
III. Factors Affecting Cell Injury in Urine
Urine osmolality. Cell injury during incubation in urine or other solutions was
assessed by testing leukocyte migratory capacity in plasma after incubation.
Changes in migration after incubation in plasma-free solutions of different osmolal-
ity are illustrated in Table 2. Cells exposed for 1 hr to iso-osmotic BES or iso-
osmotic urine at physiological pH migrated normally in plasma. However, incuba-
tion in urine specimens with an osmolality of 500 or greater markedly inhibited
subsequent migration in plasma.
Urine pH. Leukocyte migration in plasma after incubation of cells for 1 hr in
iso-osmotic solutions adjusted to different pH is shown in Table 3. BES at pHBRYANT, SUTCLIFFE, AND MCGEE
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FIG. 3. Phagocytosis in plasma after incubation in urine for (0) 15 min and (0) 60
min. Suppression of this cell function correlated with the osmolality of urine and the length
of the incubation period. Results are means of two experiments. Mean control phagocytic
index of 15-min incubation = 554; mean control phagocytic index of 60-min incubation = 616.
TABLE 3
EFFECT OF URINE pH ON INJURY OF LEUKOCYTES DURING INCUBATION IN URINF,
Incubating solution
Migration in plasma
Type of Osmolality after incubation in
solution pH (mosm/kg H20) urine (% of control)b
Urine 5.5 313 16 ± 2.8
Urine 7.3 332 105 ± 5
BESa 5.6 288 111 ± 1.4
BES 7.3 287 100 ± 2.7
Plasma 8.0 273 100C
a Buffered electrolyte solution.
bMeans of 2 experiments ± SEM.
c Mean control migration = 1.33 mm.
5.6 had no effect on the cells' subsequent ability to migrate in plasma. However,
urine specimens at comparable pH markedly reduced this function.
Concentrations of urea and NaCI in urine. Figure 4 illustrates the effect of incu-
bating leukocytes for 15 min in BES supplemented with different concentrations
of urea or NaCl prior to testing migration in plasma. Cell injury increased in pro-
portion to the hypertonicity of the incubating solution. However, injury produced
by urea was first evident at a slightly lower osmolality than that observed with
NaCl.
IV. Phagocytosis of Opsonized and Nonopsonized Bacteria in Urine
The effect of serum opsonins on phagocytic capacity of PMNs in urine is shown
in Table 4. Phagocytosis of opsonized bacteria was comparable to that observed in
plasma, even in urine at pH 5.6. Nonopsonized bacteria were much less readily
ingested by PMNs in similar urine specimens.
DISCUSSION
There is a well established relationship between the rapidity and magnitude of
the leukocyte response in the kidney and the susceptibility of the renal cortex or
120HUMAN LEUKOCYTE FUNCTION IN URINE
100 1
0
80
z
0
0
300
40 UREA
NoCP
20
300 400 500 600 700 800 900
OSMOLALITY DURING INCUBATION
FIG. 4. Leukocyte migration in plasma after incubation of cells in buffered electrolyte
solution supplemented with urea or NaCl. Incubation period was 15 min. Cell injury increased
in proportion to the concentration or either agent. Results are means of two experiments.
Mean control migration
= 1.64 mm. Brackets renresent standard error of the mean.
TABLE 4
PHAGOCYTOSIS OF OPSONIZED AND NONOPSONIZED Staphylococcus aureuS BY PMNs IN URINE
Phagocytic mixture
Phagocytic
pH Solution mosm/kg H20 Bacteria indexa
5.6 Urine 477 Nonopsonized 13
5.6 Urine 477 Opsonized 455
7.8 Plasma 288 Nonopsonized 431
7.8 Plasma 288 Opsonized 443
a Phagocytic index = number of bacteria/100 PMNs (Means of 2 experiments).
medulla to infection (7, 8). Such a relationship has not been established for the
lower urinary tract. In fact, no relationship has been established between the pres-
ence of pyuria and the resistance of the urinary tract to infection. Sanford and co-
workers have suggested that leukocytes in the urine may represent a passive spillover
of cells from the infected medullary areas (9). Similarly, Norden, Green, and Kass
found that leukocytes played virtually no role in killing of bacteria within the blad-
der (2). Cobbs and Kaye demonstrated a prompt leukocyte response to instillation
of bacteria into the urinary bladder, but their studies did not substantiate ingestion
or killing of bacteria by PMNs present in urine (3).
Certain characteristics of urine can suppress leukocyte function in vitro. A num-
ber of investigators have shown that a hyperosmotic environment markedly inhibits
the phagocytic capacity of leukocytes (1, 5, 10). Chernew and Braude were the
first to demonstrate that acid pH, extremes of osmolality, and increased concentra-
tions of urea, potassium, ammonia, creatinine, and citrate inhibited phagocytosis
by PMNs (1). Similarly, Lancaster and Allison found that high concentrations
of sodium chloride and urea impaired phagocytosis of bacteria by PMNs as well
as clumping of such cells after ingestion of bacteria (10). These authors also found
that the toxic effects of urea on leukocytes were not abolished by restoring cells
to a normal plasma environment. Knoll, Johnson, Pearce, and Rebuck observed
that urine inhibited immigration of leukocytes into Rebuck chambers. In addition,
urine impaired the phagocytic capacity of PMNs within the chambers (11). Urine
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also caused greater cell destruction and alteration of cell morphology than com-
parable concentrations of hypertonic urea or saline (12).
The extent of the inhibitory effects of urine on leukocytes has not been ade-
quately evaluated. Previous studies did not test the effect of urine on leukocyte
function in a plasma-free environment (1, 5, 10). Therefore, it is difficult to esti-
mate the effect of plasma proteins, such as bacterial opsonins, on the results ob-
tained. In addition, techniques employed did not differentiate ingested bacteria
from those merely adhering to leukocyte surfaces (1, 10). Furthermore, previous
studies usually examined PMN function shortly after cells had been exposed to
urine. Therefore, the toxic effects of urine on leukocytes were minimized, and re-
sults did not simulate conditions present in vivo in which leukocytes might be
present in urine for several hours before excretion. Experimental studies of phago-
cytosis which employ rotation of leukocyte-bacterial mixtures in test tubes also
artifically optimize opportunities for phagocytosis. Thus, it is likely that such
studies overestimated the ability of leukocytes to phagocytize bacteria in urine.
The present studies were designed in an attempt to evaluate host defense func-
tions of leukocytes in urine. Factors which might artifically enhance PMN phago-
cytic capacity were excluded as much as possible. Phagocytosis tests were done
in urine containing less than 1% plasma, and lysostaphin was used to eliminate
extracellular bacteria. Other leukocyte functions were also examined. These in-
cluded the ability of leukocytes to adhere to glass, migrate in capillary tubes, and
to interact with endotoxin. All of these functions were virtually abolished in urine.
In addition, studies were performed to determine how rapidly leukocyte function
decreased after exposure of the cells to urine. All functions tested were quickly
lost once leukocytes were exposed to urine. Urine specimens least toxic to leuko-
cytes were those with osmolalities of less than 700 mosm/kg. It is conceivable
that the loss of renal concentrating mechanism in pyelonephritis or reduced medul-
lary osmolality during water diuresis might potentiate leukocyte function in infected
urine, albeit ever so slightly.
Since leukocyte function in plasma was not significantly impaired by previous
incubation of cells in buffered electrolyte solution, urine appears to have direct
toxic effects on leukocytes which are independent of effects caused by removal
of leukocytes from the plasma environment. Cell injury attributable to extremes
of osmolality or to increased concentrations of urea or hydrogen ion are readily
demonstrable. However, relatively normal leukocyte function after incubation of
cells in iso-osmotic urine adjusted to pH 7.5 suggests that the toxic factors(s) in
urine are inactive at a neutral pH. Studies by Chernew and Braude demonstrated
that the toxic factor(s) appears to be dialyzable (1). Demonstration that leuko-
cytes are not aggregated by endotoxin in urine helps to exclude the possibility that
impaired leukocyte function in urine is mediated by endotoxin.
Retention of leukocyte phagocytic capacity has been observed in certain adverse
circumstances which completely suppress PMN migration (14), adhesion to glass,
and aggregation with other leukocytes (5). Such circumstances include a hyperos-
motic environment and divalent cation depleted plasma (13-15). However, such
studies demonstrating persistence of phagocytosis were performed with leukocytes
suspended in plasma. In contrast, the present studies show comparable suppression
of phagocytosis, migration, adhesion, and aggregation after incubation of leuko-
cytes in urine. Although the explanation for this finding is not clear, the absence
of plasma may enhance the adverse effects of extremes of pH or osmolality on
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the phagocytic capacity. That other factors are also involved is indicated by the
greater degree of cell injury in acid urine than in buffered electrolyte solution of
comparable pH.
Although prolonged (1 hr) exposure to normal urine may result in irreversible
injury to leukocytes, impaired phagocytic function observed shortly after addition
of leukocytes to urine is attributable to the lack of serum opsonins in normal urine.
The presence of opsonins dramatically enhances the phagocytic capacity of leuko-
cytes in urine. This enhancement can be demonstrated in urine of relatively high
osmolality and is clearly separable from a nonspecific effect of proteins on leuko-
cyte viability. It might be theorized that such opsonins would play little if any
role in defense against ascending infection because they are unlikely to be present
in urine. Perhaps they would contribute significantly to containment of infection
late in the course of established pyelonephritis. The existence and significance of
opsonins in the urine of patients with pyelonephritis should be determined. Simi-
larly, the effect of proteinuria, polyuria, and bacilluria on leukocyte function in
urine should be determined. Although such factors may alter leukocyte function
in urine, it is more likely that the adverse environment of the urinary bladder
abolishes all leukocyte host defense function.
The main consideration raised by the present studies is that leukocyte function
is virtually abolished in the plasma-free environment of normal urine. This suppres-
sion of function in urine is mediated in part by direct toxic effects of urine on
leukocytes and, in part, by the absence of plasma proteins necessary for optimal
leukocyte function. Cell injury is rapid and so profound that it appears likely that
intact leukocytes in urine do not contribute significantly to host defense against
ascending infection.
SUMMARY
Leukocyte migration, adhesion to glass, aggregation by endotoxin, and phagocy-
tosis of bacteria were virtually abolished in urine. Suppressed leukocyte function
in urine appeared to be mediated by direct toxic effects of urine on leukocytes.
Such effects were, in part, attributable to extremes of osmolality, pH, urea concen-
tration, and to an as yet unidentified toxic factor(s) present in normal urine. Leu-
kocyte function in plasma was not impaired by incubation in buffered electrolyte
solution or in iso-osmotic urine adjusted to pH 7.5. Thus, cell injury in urine was
not attributable to removal of leukocytes from the plasma environment. Under con-
ditions which minimized cell injury, it was possible to demonstrate that the im-
paired phagocytic capacity of leukocytes in urine was in part due to lack of serum
opsonins necessary for optimal phagocytosis.
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